Designed to support MedTech and SaMD companies building biosensor-driven apps in areas like: GLP1 companion apps with dosing schedules, side-effect tracking, and metabolic feedback loops Personalized diabetes or weight management platforms combining CGM and biosensor insights with behavior coaching Remote monitoring and telehealth solutions for clinicians managing metabolic conditions AI-driven coaching tools that layer predictive analytics over real-time device data Traditional software development forces you to juggle device connectivity, data flows, UX, backend architecture, and strict regulations, often sequentially, slowly, and at a high cost
This necessitates sophisticated manufacturing processes and quality controls
A., Tesch, P., Alkner, B
In real-world settings, semaglutide exhibited trends consistent with those observed in previous clinical trials when compared with the active comparator, further reinforcing the existing evidence supporting its use
Push the knob until it stops
Long-term follow-up of Tako-Tsubo-like syndrome: a retrospective study of 22 cases
